Correlation Between Elevation Oncology and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Enveric Biosciences, you can compare the effects of market volatilities on Elevation Oncology and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Enveric Biosciences.
Diversification Opportunities for Elevation Oncology and Enveric Biosciences
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Elevation and Enveric is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Elevation Oncology and Enveric Biosciences
Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the Enveric Biosciences. In addition to that, Elevation Oncology is 1.4 times more volatile than Enveric Biosciences. It trades about -0.07 of its total potential returns per unit of risk. Enveric Biosciences is currently generating about -0.01 per unit of volatility. If you would invest 48.00 in Enveric Biosciences on October 22, 2024 and sell it today you would lose (12.60) from holding Enveric Biosciences or give up 26.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Elevation Oncology vs. Enveric Biosciences
Performance |
Timeline |
Elevation Oncology |
Enveric Biosciences |
Elevation Oncology and Enveric Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elevation Oncology and Enveric Biosciences
The main advantage of trading using opposite Elevation Oncology and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |